A Road Map for Remote Digital Health Technology for Motor Neuron Disease.
暂无分享,去创建一个
Kit C B Roes | Angela Genge | Orla Hardiman | Anita Beelen | Ruben P A van Eijk | Esther T Kruitwagen | Deirdre Murray | Ratko Radakovic | Esther Hobson | Liam Knox | Jochem Helleman | Tom Burke | Miguel Ángel Rubio Pérez | Evy Reviers | Frederik J Steyn | Shyuan Ngo | John Eaglesham | Leonard H van den Berg | Christopher J McDermott | O. Hardiman | L. H. van den Berg | A. Beelen | R. V. van Eijk | C. Mcdermott | Ratko Radakovic | K. Roes | Jochem Helleman | S. Ngo | F. Steyn | A. Genge | John Eaglesham | Esther V Hobson | D. Murray | L. Knox | M. R. Rubio Pérez | Evy Reviers | Tom Burke
[1] S. Paganoni,et al. Telemedicine to innovate amyotrophic lateral sclerosis multidisciplinary care: The time has come , 2019, Muscle & nerve.
[2] S. Steinhubl,et al. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial , 2018, JAMA.
[3] R. Chiaramonte,et al. Acoustic analysis of voice in bulbar amyotrophic lateral sclerosis: a systematic review and meta-analysis of studies , 2019, Logopedics, phoniatrics, vocology.
[4] A. Al-Chalabi,et al. Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] Max A. Little,et al. Technology in Parkinson's disease: Challenges and opportunities , 2016, Movement disorders : official journal of the Movement Disorder Society.
[6] A. Moser,et al. Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis , 2017, The European journal of general practice.
[7] Jennifer C. Goldsack,et al. Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature Review , 2018, Digital Biomarkers.
[8] Using technology to improve access to specialist care in amyotrophic lateral sclerosis: A systematic review , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[9] L. H. van den Berg,et al. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials , 2019, Neurology.
[10] L. H. van den Berg,et al. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[11] S. Mawson,et al. The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[12] P. Kothare,et al. Harnessing the Potential of Emerging Digital Health and Biological Sampling Technologies for Clinical Drug Development: Promise to Reality , 2018, Clinical pharmacology and therapeutics.
[13] A. Al-Chalabi,et al. A proposed staging system for amyotrophic lateral sclerosis , 2012, Brain : a journal of neurology.
[14] A. Al-Chalabi,et al. Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study , 2019, JMIR mHealth and uHealth.
[15] Stephanie H. Felgoise,et al. A Qualitative Study of Multidisciplinary ALS Clinic Use in the United States , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[16] S. Mawson,et al. Process evaluation and exploration of telehealth in motor neuron disease in a UK specialist centre , 2019, BMJ Open.
[17] R. Henderson,et al. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach , 2017, Journal of multidisciplinary healthcare.
[18] O. Hardiman,et al. Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis , 2018, BMJ Open.
[19] B. Bloem,et al. The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders. , 2020, JAMA neurology.
[20] O. Hardiman,et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[21] L. H. van den Berg,et al. Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study , 2019, Journal of Neurology.
[22] O. Hardiman,et al. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial , 2013, The Lancet Neurology.
[23] A. Al-Chalabi,et al. TRICALS: creating a highway toward a cure , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[24] S. Paganoni,et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID‐19 pandemic: Challenges and opportunities , 2020, Muscle & nerve.
[25] Esther T Kruitwagen,et al. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review , 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[26] A. Chiò,et al. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[27] Esther T Kruitwagen,et al. Telehealth as part of specialized ALS care: feasibility and user experiences with “ALS home-monitoring and coaching” , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[28] M. Gagnon,et al. Some Multidimensional Unintended Consequences of Telehealth Utilization: A Multi-Project Evaluation Synthesis , 2019, International journal of health policy and management.
[29] Ioannis Tarnanas,et al. Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials , 2018, Alzheimer's & dementia.
[30] S. Mawson,et al. Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study , 2019, BMJ Open.
[31] ANNETTE DE VITO DABBS,et al. User-Centered Design and Interactive Health Technologies for Patients , 2009, Computers, informatics, nursing : CIN.
[32] A. Al-Chalabi,et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS , 2018, Neurology.
[33] Visar Berisha,et al. ALS longitudinal studies with frequent data collection at home: study design and baseline data , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[34] Karel G M Moons,et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model , 2018, The Lancet Neurology.
[35] A. Chiò,et al. ALS clinical trials , 2011, Neurology.
[36] Paolo Bonato,et al. A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies , 2019, Movement disorders : official journal of the Movement Disorder Society.
[37] Visar Berisha,et al. Improved ALS clinical trials through frequent at‐home self‐assessment: a proof of concept study , 2020, Annals of clinical and translational neurology.
[38] S. Edland,et al. Power calculations for clinical trials in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[39] T. Hortobágyi,et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.